A reference interval is not a target, and a result outside one is not a diagnosis
The arithmetic of the reference change value, worked for the analytes that matter here.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Page 3 of 11 of this archive, newest first.
The arithmetic of the reference change value, worked for the analytes that matter here.
We separate what is supported, what is reasonable, and what is folklore, and we do not pretend the boundaries are crisp.
Dietary measures are widely recommended, plausible on mechanism, and supported mainly by observational data and clinical experience.
A drug that delays gastric emptying complicates the assumption behind every fasting instruction in perioperative medicine. The professional bodies have moved twice on this…
Mass and function are different endpoints and training affects them differently. Most coverage treats them as one.
The receptor populations that produce satiety and the ones that produce nausea overlap substantially. That is why the ceiling of this drug class is where it is, and it is…
The clinical effect profile is almost fully predictable from where the receptor is expressed, which is unusual and useful.
Holding a dose before a procedure has a kinetic problem: a weekly drug with a seven-day half-life cannot be cleared by skipping one injection.
The clinical effect profile is almost fully predictable from where the receptor is expressed, which is unusual and useful.
Almost nothing in the standard management repertoire has been tested in a randomised trial in this specific population. We say what is extrapolated and from where.
A substantial proportion of the abnormal results generated during rapid weight loss are consequences of the weight loss rather than findings about the person.
Reduced intake is a plausible mechanism for deficiency. Reduced absorption is not, and the two are conflated in most of the advice.
We set out the questions that distinguish a symptom to manage from a dose to change.
The instrument determines the answer more than the drug does, and the trade quotes the answer without naming the instrument.
Almost every figure in circulation about tolerability comes from six publications. This is what they say.
What was pre-specified, what was exploratory, and what was calculated afterwards by people who did not run the trial.
The receptor populations that produce satiety and the ones that produce nausea overlap substantially. That is why the ceiling of this drug class is where it is, and it is…
The compartment called lean mass contains water, glycogen, viscera and skin. Only some of it is the tissue anybody is worried about.
The evidence base is one secondary analysis, several small studies and a large amount of extrapolation from bariatric surgery.
A substudy powered to describe a mean is not a substudy powered to detect a clinically meaningful individual change.